MTORC1 determines autophagy through ULK1 regulation in skeletal muscle

被引:59
作者
Castets, Perrine [1 ,2 ,3 ]
Rueegg, Markus A. [1 ]
机构
[1] Univ Basel, Biozentrum, Basel, Switzerland
[2] Univ Basel Hosp, Pharmazentrum, Dept Neurol, Neuromuscular Res Ctr, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Pharmazentrum, Dept Biomed, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
MTORC1; FOXO; skeletal muscle; autophagy; ULK1; atrophy; myopathy;
D O I
10.4161/auto.25722
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Autophagy impairment has been implicated in several muscle disorders and in age-related dysfunction. Although previous reports pointed to FOXO as a positive regulator of autophagy in skeletal muscle, it remained unclear what is triggering autophagy. We found that TSC muscle knockout (TSCmKO) mice, characterized by specific depletion of TSC1 in skeletal muscle, and thus constant activation of MTORC1, develop a late-onset myopathy marked by the accumulation of autophagic substrates. In those mice, autophagy induction is blocked despite FOXO activation because of constant MTORC1-dependent inhibition of ULK1. Treatment of TSCmKO mice with rapamycin is sufficient to restore autophagy and to alleviate, at least in part, the myopathy. Inversely, inactivation of the MTORC1 pathway in RPTOR-depleted muscles triggers LC3B lipidation in spite of FOXO inhibition. In conclusion, MTORC1 constitutes the master regulator of autophagy induction in skeletal muscle and its deregulation leads to pathologic alterations of muscle homeostasis.
引用
收藏
页码:1435 / 1437
页数:3
相关论文
empty
未找到相关数据